Clinical trial

Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

NCT00426023 · Campus Bio-Medico University, Other · Completed

Key facts

NCT number NCT00426023
Title Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
Official title Multicenter, Randomised, Double Masked, Controlled Studies on the Efficacy of Cyclosporine Eye Drop Treatment in Preventing Vernal Keratoconjunctivitis (VKC) Relapses and in Treating the Acute Phase.
Lead sponsor Campus Bio-Medico University, Other
Collaborators University of Genova University of Padova
Status Completed
Phase Phase 3
Study type Interventional
Conditions Vernal Keratoconjunctivitis
Intervention type Drug
Interventions Cyclosporine A 0, 05% eye drop, ketotifen fumarate 0.025% eye drops
Enrollment 48
Start date Feb 1, 2007
Primary completion Oct 1, 2008
Completion Oct 1, 2008
First posted Jan 24, 2007
Last update posted Jan 28, 2009
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies